Showing results (121-130 of 242) with videos related to
Sort By:
Pageof 25
Expert Opinion on Drug Delivery|May 28, 2020
Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical updateHideyuki Kawashima, Masafumi Ono, Norihiro Kogame, et al.Future Cardiology|September 10, 2020
The ultra-thin strut sirolimus-eluting coronary stent: SUPRAFLEXChao Gao, Norihiro Kogame, Rodrigo Modolo, et al.Plos One|August 23, 2012
High expression of nuclear factor 90 (NF90) leads to mitochondrial degradation in skeletal and cardiac musclesTakuma Higuchi, Shuji Sakamoto, Yoshihiko Kakinuma, et al.Gastroenterology|December 19, 2015
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient ElastographyKento Imajo, Takaomi Kessoku, Yasushi Honda, et al.BMC Gastroenterology|January 7, 2012
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease populationYoshio Sumida, Masato Yoneda, Hideyuki Hyogo, et al.Diagnostics (Basel, Switzerland)|May 1, 2025
A Noninvasive Method of Diagnosing Metabolic Dysfunction-Associated Steatohepatitis Using Cytokeratin-18 Fragment and FIB-3 IndexTomoko Tadokoro, Miwa Kawanaka, Hirokazu Takahashi, et al.Cancers|June 28, 2023
Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination TherapyKyoko Oura, Asahiro Morishita, Takushi Manabe, et al.European Journal of Gastroenterology & Hepatology|August 2, 2021
Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver diseaseToshifumi Tada, Toshiji Saibara, Masafumi Ono, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 15, 2020
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trialHironori Hara, Chao Gao, Norihiro Kogame, et al.Anticancer Research|July 27, 2022
Effect of Aspirin on G0/G1 Cell Cycle Arrest and microRNA Signatures in Pancreatic Adenocarcinoma CellsRyota Nakabayashi, Shintaro Fujihara, Hisakazu Iwama, et al.Pageof 25